Title: President and Chief Executive Officer
Company: KTK Pharma Solutions LLC
Location: Quakertown, Pennsylvania, United States
Paul Krauthauser, President and Chief Executive Officer at KTK Pharma Solutions LLC, has been recognized by Marquis Who’s Who Top Professional for dedication, achievements, and leadership in Pharmaceuticals.
Mr. Krauthauser is lauded for his extensive executive leadership expertise in the pharmaceutical space. Since 2023, he has been the president and chief executive officer of KTK Pharma Solutions LLC. Based in Quakertown, Pennsylvania, his full-service generic pharma consulting firm is comprised of a network of subject matter expert consultants experienced in the generic pharmaceutical industry.
In addition to his role at KTK Pharma Solutions LLC, Mr. Krauthauser began serving as the chief commercial officer at Carnegie Pharmaceuticals LLC in 2024. This pharmaceutical manufacturing company in Delran, New Jersey, specializes in developing one-of-a-kind generic and branded products with development barriers. Passionate about this recent opportunity, Mr. Krauthauser emphasizes that generic medications are accessible and affordable for everyone.
A leader in the pharmaceutical sector for over 25 years, Mr. Krauthauser began his career as an analytic research and development intern at Teva Pharmaceuticals from 1996 to 1997. The organization subsequently hired him full-time as an associate chemist in analytic research and development from 1997 to 2000. Over the next decade, Mr. Krauthauser served as a scientist, product manager, marketing director and national sales director.
Following his tenure at Teva Pharmaceuticals, Mr. Krauthauser became a corporate account manager at Apotex Inc. from 2008 to 2009, a director of national accounts at Sandoz between 2009 and 2013, a senior vice president of sales and marketing at Rising Pharmaceuticals from 2013 to 2017, and a senior vice president of commercial operations at Aurobindo Pharma USA Inc. between 2017 and 2018. Additionally, Mr. Krauthauser served as the chief operating officer at Macleods Pharmaceuticals from 2018 to 2022 and as the chief commercial officer at Granules Pharmaceuticals Inc. between 2022 and 2023. These leadership positions have been instrumental in his ability to build high-functioning, high-performance teams.
Highly educated, Mr. Krauthauser studied at DeSales University in Center Valley, Pennsylvania, receiving a Bachelor of Science in chemistry in 1997. He also completed a Master of Business Administration in marketing at Saint Joseph’s University in Philadelphia in 2002. Mr. Krauthauser’s decision to pursue advanced education was encouraged by several of his colleagues. The opportunity was instrumental in blending his technical expertise with a solid business acumen.
Apart from his primary career objectives, Mr. Krauthauser enjoys providing mentorship to interns and derives satisfaction from working with them. He believes that passing on his decades of wisdom and experience to the next generation of industry leaders is paramount to his success and the success of the industry.
In light of his professional success, Mr. Krauthauser was recognized as one of the Top 10 Chief Operating Officers of the Year. As he prepares for the future, he aims to witness significant changes in the generic pharmaceutical industry. He also emphasizes that the generic industry should not be equated with the brand pharmaceutical industry, which is fundamentally different. Moreover, Mr. Krauthauser stresses the need to highlight the economic aspects of pharmaceuticals, specifically generic drugs, creating a sector that is more accessible and more affordable while streamlining the supply chain and eliminating unnecessary costs.
For more information, please visit:
Contact Mr. Krauthauser:
